Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 42 | 2025 | 905 | 13.160 |
Why?
|
| Apolipoprotein E4 | 17 | 2025 | 222 | 6.740 |
Why?
|
| Alzheimer Disease | 23 | 2025 | 1774 | 5.300 |
Why?
|
| Aged | 82 | 2025 | 7669 | 3.800 |
Why?
|
| Cognition | 30 | 2024 | 1104 | 3.540 |
Why?
|
| Female | 88 | 2025 | 12677 | 2.970 |
Why?
|
| tau Proteins | 6 | 2025 | 197 | 2.940 |
Why?
|
| Chicago | 29 | 2025 | 808 | 2.890 |
Why?
|
| Male | 78 | 2025 | 12453 | 2.820 |
Why?
|
| Neurofilament Proteins | 4 | 2025 | 16 | 2.760 |
Why?
|
| Cognition Disorders | 14 | 2018 | 807 | 2.750 |
Why?
|
| Humans | 105 | 2025 | 22848 | 2.640 |
Why?
|
| Stroke | 6 | 2023 | 207 | 2.560 |
Why?
|
| Aged, 80 and over | 41 | 2025 | 4055 | 2.540 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 96 | 2.420 |
Why?
|
| Longitudinal Studies | 28 | 2025 | 1122 | 2.400 |
Why?
|
| Aging | 14 | 2025 | 1290 | 2.280 |
Why?
|
| Cohort Studies | 25 | 2025 | 1621 | 2.150 |
Why?
|
| Biomarkers | 11 | 2025 | 453 | 2.110 |
Why?
|
| Risk Factors | 25 | 2025 | 1942 | 2.000 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2025 | 32 | 1.840 |
Why?
|
| Apolipoproteins E | 8 | 2023 | 217 | 1.820 |
Why?
|
| Alleles | 9 | 2024 | 173 | 1.800 |
Why?
|
| Exercise | 9 | 2023 | 305 | 1.670 |
Why?
|
| Blood Pressure | 3 | 2024 | 160 | 1.570 |
Why?
|
| White Matter | 3 | 2022 | 116 | 1.520 |
Why?
|
| Activities of Daily Living | 9 | 2018 | 539 | 1.510 |
Why?
|
| Prospective Studies | 15 | 2025 | 1528 | 1.420 |
Why?
|
| Population Surveillance | 3 | 2021 | 103 | 1.390 |
Why?
|
| Dementia | 9 | 2024 | 484 | 1.330 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 235 | 1.240 |
Why?
|
| Vitamin E | 2 | 2023 | 42 | 1.230 |
Why?
|
| Intermediate Filaments | 4 | 2023 | 16 | 1.210 |
Why?
|
| Incidence | 12 | 2025 | 649 | 1.170 |
Why?
|
| Genotype | 7 | 2024 | 301 | 1.170 |
Why?
|
| Disease Progression | 11 | 2019 | 554 | 1.120 |
Why?
|
| Memory Disorders | 3 | 2024 | 128 | 1.120 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2024 | 32 | 1.070 |
Why?
|
| Loneliness | 2 | 2025 | 56 | 1.070 |
Why?
|
| Diet, Mediterranean | 3 | 2024 | 90 | 1.040 |
Why?
|
| Mortality | 4 | 2021 | 75 | 1.020 |
Why?
|
| United States | 12 | 2024 | 1726 | 0.930 |
Why?
|
| Lipids | 1 | 2025 | 46 | 0.920 |
Why?
|
| Social Isolation | 1 | 2025 | 29 | 0.910 |
Why?
|
| Disability Evaluation | 4 | 2014 | 223 | 0.900 |
Why?
|
| Dietary Fats | 1 | 2024 | 37 | 0.870 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.860 |
Why?
|
| Depression | 4 | 2014 | 375 | 0.810 |
Why?
|
| Neuropathology | 3 | 2021 | 73 | 0.810 |
Why?
|
| Vitamin D | 1 | 2022 | 33 | 0.770 |
Why?
|
| Healthy Lifestyle | 5 | 2024 | 36 | 0.760 |
Why?
|
| Independent Living | 5 | 2025 | 265 | 0.750 |
Why?
|
| Antihypertensive Agents | 2 | 2021 | 45 | 0.750 |
Why?
|
| Membrane Proteins | 1 | 2021 | 144 | 0.680 |
Why?
|
| Geriatric Assessment | 5 | 2021 | 177 | 0.660 |
Why?
|
| Follow-Up Studies | 11 | 2024 | 1494 | 0.630 |
Why?
|
| Neuropsychological Tests | 11 | 2018 | 982 | 0.610 |
Why?
|
| Time Factors | 10 | 2021 | 1220 | 0.590 |
Why?
|
| Diet | 4 | 2023 | 199 | 0.580 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 311 | 0.540 |
Why?
|
| Art | 1 | 2016 | 1 | 0.540 |
Why?
|
| Mental Status and Dementia Tests | 3 | 2023 | 48 | 0.520 |
Why?
|
| Music | 1 | 2016 | 22 | 0.520 |
Why?
|
| Diabetes Complications | 1 | 2016 | 49 | 0.510 |
Why?
|
| Life Style | 5 | 2022 | 127 | 0.510 |
Why?
|
| Models, Statistical | 2 | 2021 | 110 | 0.510 |
Why?
|
| Obesity | 6 | 2014 | 263 | 0.490 |
Why?
|
| Prevalence | 3 | 2023 | 377 | 0.490 |
Why?
|
| Mobility Limitation | 2 | 2015 | 77 | 0.480 |
Why?
|
| Cognitive Aging | 4 | 2021 | 70 | 0.470 |
Why?
|
| Depressive Disorder | 1 | 2015 | 121 | 0.460 |
Why?
|
| Body Mass Index | 6 | 2018 | 400 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 135 | 0.450 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 16 | 0.440 |
Why?
|
| Motor Activity | 2 | 2015 | 239 | 0.440 |
Why?
|
| Dopamine Agents | 1 | 2014 | 7 | 0.440 |
Why?
|
| Memantine | 1 | 2014 | 6 | 0.440 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2021 | 233 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 233 | 0.430 |
Why?
|
| Antioxidants | 1 | 2014 | 56 | 0.420 |
Why?
|
| Health Status Disparities | 1 | 2013 | 69 | 0.390 |
Why?
|
| Memory, Episodic | 3 | 2018 | 98 | 0.390 |
Why?
|
| Diagnosis | 1 | 2011 | 18 | 0.380 |
Why?
|
| Area Under Curve | 1 | 2011 | 55 | 0.370 |
Why?
|
| Medical Informatics | 1 | 2011 | 7 | 0.370 |
Why?
|
| Linear Models | 3 | 2016 | 205 | 0.360 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 377 | 0.350 |
Why?
|
| Refusal to Participate | 1 | 2010 | 2 | 0.350 |
Why?
|
| Disabled Persons | 1 | 2012 | 100 | 0.350 |
Why?
|
| Middle Aged | 21 | 2019 | 7555 | 0.310 |
Why?
|
| Age of Onset | 3 | 2014 | 79 | 0.300 |
Why?
|
| Genetic Loci | 3 | 2018 | 44 | 0.300 |
Why?
|
| Postmenopause | 7 | 2006 | 47 | 0.270 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 947 | 0.270 |
Why?
|
| Hypertension | 2 | 2024 | 156 | 0.250 |
Why?
|
| Triglycerides | 2 | 2025 | 54 | 0.250 |
Why?
|
| Neuroticism | 2 | 2023 | 31 | 0.240 |
Why?
|
| Hypoglycemic Agents | 2 | 2016 | 27 | 0.240 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.230 |
Why?
|
| Heterozygote | 1 | 2025 | 71 | 0.230 |
Why?
|
| Environmental Exposure | 1 | 2024 | 14 | 0.230 |
Why?
|
| Cholesterol | 1 | 2025 | 59 | 0.230 |
Why?
|
| Survivors | 3 | 2022 | 49 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.230 |
Why?
|
| Air Pollution | 1 | 2024 | 14 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 18 | 0.230 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 269 | 0.230 |
Why?
|
| Adult | 11 | 2023 | 6584 | 0.220 |
Why?
|
| Risk Assessment | 2 | 2024 | 485 | 0.220 |
Why?
|
| Sex Factors | 2 | 2022 | 381 | 0.210 |
Why?
|
| Florida | 1 | 2023 | 15 | 0.210 |
Why?
|
| Tocopherols | 1 | 2023 | 7 | 0.200 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 11 | 0.200 |
Why?
|
| Regression Analysis | 4 | 2011 | 210 | 0.200 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 7 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.200 |
Why?
|
| Brain Infarction | 1 | 2023 | 54 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 18 | 0.200 |
Why?
|
| Age Factors | 2 | 2022 | 657 | 0.200 |
Why?
|
| Dietary Supplements | 1 | 2022 | 54 | 0.190 |
Why?
|
| Life Expectancy | 1 | 2022 | 26 | 0.190 |
Why?
|
| Cognitive Reserve | 1 | 2022 | 35 | 0.190 |
Why?
|
| Brain | 4 | 2024 | 1324 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2014 | 191 | 0.190 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 3 | 0.180 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 19 | 0.180 |
Why?
|
| Cost of Illness | 1 | 2021 | 43 | 0.180 |
Why?
|
| Early Diagnosis | 1 | 2020 | 43 | 0.170 |
Why?
|
| Noise | 1 | 2020 | 23 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 149 | 0.170 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 76 | 0.170 |
Why?
|
| Neuroimaging | 1 | 2020 | 108 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 118 | 0.160 |
Why?
|
| Residence Characteristics | 1 | 2020 | 172 | 0.160 |
Why?
|
| Confidence Intervals | 2 | 2017 | 82 | 0.150 |
Why?
|
| Phototherapy | 1 | 2019 | 26 | 0.150 |
Why?
|
| Hippocampus | 1 | 2020 | 222 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 11 | 0.150 |
Why?
|
| Social Networking | 1 | 2018 | 8 | 0.150 |
Why?
|
| Healthy Aging | 1 | 2018 | 13 | 0.150 |
Why?
|
| Interviews as Topic | 2 | 2016 | 109 | 0.150 |
Why?
|
| Behavioral Symptoms | 1 | 2018 | 8 | 0.150 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 18 | 0.150 |
Why?
|
| Odds Ratio | 2 | 2017 | 241 | 0.150 |
Why?
|
| Surveys and Questionnaires | 5 | 2016 | 977 | 0.150 |
Why?
|
| Nursing Homes | 1 | 2018 | 37 | 0.150 |
Why?
|
| Parkinson Disease | 2 | 2022 | 556 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 249 | 0.140 |
Why?
|
| Social Environment | 1 | 2018 | 55 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 125 | 0.140 |
Why?
|
| Defecation | 1 | 2017 | 6 | 0.140 |
Why?
|
| Starch | 1 | 2017 | 11 | 0.140 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 66 | 0.140 |
Why?
|
| Low Back Pain | 1 | 2019 | 121 | 0.140 |
Why?
|
| Microspheres | 1 | 2017 | 21 | 0.140 |
Why?
|
| Dietary Fiber | 1 | 2017 | 26 | 0.140 |
Why?
|
| Prebiotics | 1 | 2017 | 20 | 0.140 |
Why?
|
| Invasive Fungal Infections | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mucormycosis | 1 | 2017 | 7 | 0.130 |
Why?
|
| Frozen Sections | 1 | 2017 | 13 | 0.130 |
Why?
|
| Aspergillosis | 1 | 2017 | 13 | 0.130 |
Why?
|
| Inflammation | 1 | 2018 | 226 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.130 |
Why?
|
| Parity | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproduction | 1 | 2016 | 7 | 0.130 |
Why?
|
| Iodide Peroxidase | 1 | 2018 | 113 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 32 | 0.130 |
Why?
|
| Warfare | 1 | 2016 | 8 | 0.130 |
Why?
|
| Terrorism | 1 | 2016 | 7 | 0.130 |
Why?
|
| Interview, Psychological | 2 | 2014 | 33 | 0.130 |
Why?
|
| Reading | 1 | 2016 | 35 | 0.130 |
Why?
|
| Clinical Competence | 2 | 2015 | 184 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 49 | 0.120 |
Why?
|
| Overweight | 2 | 2014 | 58 | 0.120 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 6 | 0.120 |
Why?
|
| Self Report | 1 | 2016 | 174 | 0.120 |
Why?
|
| Health Status | 2 | 2014 | 173 | 0.120 |
Why?
|
| Insulin | 2 | 2014 | 75 | 0.120 |
Why?
|
| Adipose Tissue | 3 | 2005 | 65 | 0.120 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 4 | 0.120 |
Why?
|
| Carbohydrates | 1 | 2015 | 5 | 0.120 |
Why?
|
| Blood Glucose | 2 | 2014 | 89 | 0.120 |
Why?
|
| Chromatography, Gas | 1 | 2015 | 9 | 0.120 |
Why?
|
| Urinalysis | 1 | 2015 | 7 | 0.120 |
Why?
|
| Models, Genetic | 1 | 2015 | 24 | 0.120 |
Why?
|
| Rhinitis | 1 | 2017 | 142 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2015 | 49 | 0.120 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 126 | 0.110 |
Why?
|
| Sinusitis | 1 | 2017 | 159 | 0.110 |
Why?
|
| Hospitalization | 2 | 2014 | 272 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 65 | 0.110 |
Why?
|
| Intelligence Tests | 1 | 2014 | 15 | 0.110 |
Why?
|
| Cats | 1 | 2014 | 26 | 0.110 |
Why?
|
| Hypoglycemia | 1 | 2014 | 12 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 108 | 0.110 |
Why?
|
| Models, Psychological | 1 | 2014 | 48 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 270 | 0.110 |
Why?
|
| Colitis, Ulcerative | 1 | 2014 | 53 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 144 | 0.110 |
Why?
|
| Ultrasonography | 1 | 2015 | 205 | 0.100 |
Why?
|
| Mindfulness | 1 | 2014 | 33 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 200 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 300 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 101 | 0.100 |
Why?
|
| Emergency Medicine | 1 | 2015 | 93 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 124 | 0.100 |
Why?
|
| Social Support | 1 | 2014 | 156 | 0.100 |
Why?
|
| Colonoscopy | 1 | 2013 | 68 | 0.100 |
Why?
|
| Adenoma | 1 | 2013 | 58 | 0.100 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 37 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2011 | 33 | 0.090 |
Why?
|
| Gait | 1 | 2015 | 363 | 0.090 |
Why?
|
| Breast Neoplasms | 3 | 2004 | 337 | 0.090 |
Why?
|
| ROC Curve | 1 | 2011 | 121 | 0.090 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 106 | 0.090 |
Why?
|
| Elder Abuse | 1 | 2011 | 34 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 95 | 0.090 |
Why?
|
| Frail Elderly | 1 | 2010 | 39 | 0.090 |
Why?
|
| Self Care | 1 | 2010 | 75 | 0.080 |
Why?
|
| Testosterone | 3 | 2004 | 20 | 0.080 |
Why?
|
| Quality of Life | 1 | 2014 | 504 | 0.080 |
Why?
|
| Computer Simulation | 1 | 2010 | 160 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 401 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 305 | 0.070 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 357 | 0.070 |
Why?
|
| Young Adult | 3 | 2018 | 1721 | 0.070 |
Why?
|
| Animals | 1 | 2014 | 3025 | 0.070 |
Why?
|
| Common Cold | 1 | 2006 | 6 | 0.070 |
Why?
|
| C-Reactive Protein | 2 | 2018 | 91 | 0.060 |
Why?
|
| Pilot Projects | 2 | 2019 | 334 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 254 | 0.060 |
Why?
|
| Smoking Prevention | 1 | 2005 | 17 | 0.060 |
Why?
|
| Feces | 2 | 2017 | 87 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2005 | 28 | 0.060 |
Why?
|
| Observer Variation | 2 | 2015 | 83 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Peptide Hormones | 1 | 2004 | 3 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2005 | 45 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2017 | 295 | 0.060 |
Why?
|
| Copper | 1 | 2024 | 18 | 0.060 |
Why?
|
| Diet, Reducing | 1 | 2004 | 12 | 0.060 |
Why?
|
| Attitude to Health | 1 | 2005 | 74 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 23 | 0.060 |
Why?
|
| Sulfotransferases | 1 | 2004 | 6 | 0.060 |
Why?
|
| Androgens | 1 | 2004 | 7 | 0.060 |
Why?
|
| Glucuronosyltransferase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Metabolic Syndrome | 1 | 2005 | 45 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2018 | 180 | 0.060 |
Why?
|
| Parents | 1 | 2005 | 86 | 0.060 |
Why?
|
| Estrogens | 1 | 2004 | 23 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2003 | 10 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 713 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 11 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 53 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 74 | 0.050 |
Why?
|
| Leisure Activities | 1 | 2022 | 9 | 0.050 |
Why?
|
| Logistic Models | 2 | 2013 | 320 | 0.050 |
Why?
|
| Tremor | 1 | 2022 | 65 | 0.050 |
Why?
|
| Diet Surveys | 1 | 2021 | 24 | 0.050 |
Why?
|
| Washington | 3 | 2006 | 5 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 74 | 0.040 |
Why?
|
| Autopsy | 1 | 2021 | 275 | 0.040 |
Why?
|
| Child | 2 | 2018 | 990 | 0.040 |
Why?
|
| Memory | 2 | 2011 | 241 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2020 | 65 | 0.040 |
Why?
|
| Smoking | 2 | 2015 | 163 | 0.040 |
Why?
|
| Pain Threshold | 1 | 2019 | 23 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 24 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Schizophrenia | 1 | 2018 | 40 | 0.040 |
Why?
|
| Neurotic Disorders | 1 | 2018 | 18 | 0.040 |
Why?
|
| Threonine | 1 | 2018 | 8 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2018 | 20 | 0.040 |
Why?
|
| Alanine | 1 | 2018 | 11 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 1775 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2018 | 54 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 48 | 0.040 |
Why?
|
| Awareness | 1 | 2018 | 37 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 80 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 19 | 0.040 |
Why?
|
| Liver | 1 | 2018 | 127 | 0.030 |
Why?
|
| Constipation | 1 | 2017 | 14 | 0.030 |
Why?
|
| Fermentation | 1 | 2017 | 13 | 0.030 |
Why?
|
| Educational Status | 1 | 2018 | 253 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2017 | 28 | 0.030 |
Why?
|
| Chronic Pain | 1 | 2019 | 128 | 0.030 |
Why?
|
| Mucor | 1 | 2017 | 5 | 0.030 |
Why?
|
| Aspergillus | 1 | 2017 | 7 | 0.030 |
Why?
|
| Nasal Surgical Procedures | 1 | 2017 | 10 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2017 | 39 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 12 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 43 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 11 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 8 | 0.030 |
Why?
|
| Russia | 1 | 2016 | 2 | 0.030 |
Why?
|
| Jews | 1 | 2016 | 3 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 2016 | 8 | 0.030 |
Why?
|
| Israel | 1 | 2016 | 12 | 0.030 |
Why?
|
| Arabs | 1 | 2016 | 8 | 0.030 |
Why?
|
| Nose | 1 | 2017 | 36 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 33 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 147 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 500 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 220 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 290 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 303 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 20 | 0.030 |
Why?
|
| Gallbladder | 1 | 2015 | 3 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 5 | 0.030 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 133 | 0.030 |
Why?
|
| Endoscopy | 1 | 2017 | 171 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 42 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 5 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3062 | 0.030 |
Why?
|
| Decision Making | 1 | 2017 | 182 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2015 | 12 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 35 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2015 | 35 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2015 | 30 | 0.030 |
Why?
|
| Permeability | 1 | 2015 | 87 | 0.030 |
Why?
|
| Kinetics | 1 | 2015 | 145 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 64 | 0.030 |
Why?
|
| China | 1 | 2014 | 44 | 0.030 |
Why?
|
| Body Weight | 2 | 2004 | 116 | 0.030 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2014 | 5 | 0.030 |
Why?
|
| Interleukins | 1 | 2014 | 15 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 54 | 0.030 |
Why?
|
| Estrone | 2 | 2004 | 7 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2015 | 96 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2014 | 29 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2004 | 13 | 0.030 |
Why?
|
| Estradiol | 2 | 2004 | 43 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 138 | 0.030 |
Why?
|
| Patient Compliance | 2 | 2005 | 117 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 34 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 549 | 0.030 |
Why?
|
| Attention | 1 | 2014 | 96 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 582 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 110 | 0.030 |
Why?
|
| Critical Illness | 1 | 2014 | 110 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 643 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2013 | 86 | 0.020 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 1 | 0.020 |
Why?
|
| Length of Stay | 1 | 2014 | 279 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2014 | 254 | 0.020 |
Why?
|
| Perception | 1 | 2011 | 63 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 178 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 11 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 12 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 299 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 172 | 0.020 |
Why?
|
| Caregivers | 1 | 2011 | 168 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 685 | 0.020 |
Why?
|
| Influenza Vaccines | 1 | 2006 | 11 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 2006 | 20 | 0.020 |
Why?
|
| Health Education | 1 | 2005 | 41 | 0.010 |
Why?
|
| Leptin | 1 | 2005 | 19 | 0.010 |
Why?
|
| Ghrelin | 1 | 2004 | 2 | 0.010 |
Why?
|
| Body Size | 1 | 2004 | 11 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2005 | 40 | 0.010 |
Why?
|
| Homeostasis | 1 | 2005 | 65 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 52 | 0.010 |
Why?
|
| Arylsulfotransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 18 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2004 | 22 | 0.010 |
Why?
|
| Energy Intake | 1 | 2004 | 78 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 47 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 50 | 0.010 |
Why?
|
| New Mexico | 1 | 2003 | 2 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2003 | 3 | 0.010 |
Why?
|
| Anthropometry | 1 | 2003 | 28 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 70 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2003 | 307 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 588 | 0.010 |
Why?
|